Home
About
The Industry
Getting Funded
Brokers
Press Releases
Contact

© 2010 Company Name. All rights reserved.
390 N. Orange Ave, Ste 1800, Orlando FL 32802 | email: g.herard@gillesherard.com | call: (407) 540-0142
More About The Industry
Pharmaceuticals/ Biotechnology/ Biopharmaceuticals
Most traditional pharmaceutical drugs are relatively simple molecules that have been found primarily through trial and error to treat the symptoms of a disease or illness. Biopharmaceuticals are large biological molecules like proteins and these usually target the underlying mechanisms and pathways of a malady; it is a relatively young industry. They can deal with targets in humans that may not be accessible with traditional medicines. 

The modern biotechnology industry has been instrumental in developing molecular diagnostic devices that can be used to define the target patient population for a given biopharmaceutical.  


OUR PRIDE
OUR EXPERTISE
OUR STRENGTH
OUR CONTACTS™
DID YOU KNOW?
We charge:
  * No Upfront Fees
  * No Application Fees
  * No Revision Fees
  * No Stand-By Fees
  * No Retainers
In committing our own funds, we can help you realize your project!
We are keenly aware of the fact that in this market, private equity investing in biopharmaceutical projects is first and foremost a 'people business' and we work by the fundamental philosophy and principle that our word is our bond.
gilles herard merchant banker biopharma project financing
Modern biotechnology can be used to manufacture existing medicines relatively easily and cheaply. the first genetically engineered products were medicines designed to treat human diseases (ex: synthetic insulin). Genomic knowledge of the genes involved in diseases , disease pathways, and drug-response sites are expected to lead to the discovery of thousands more new targets.​
Getting the Patent
When a biopharmaceutical is developed, the company will typically apply for a patent, which is a grant for exclusive manufacturing rights. This is the primary means by which the developer(s) of the drug can recover the investment cost for development of the biopharmaceutical. The patent laws in the US and Europe differ somewhat on the requirements for a patent, with the European requirements are perceived as more difficult to satisfy. 

Generally, there is rather strict control exerted over the commercial distribution of a pharmaceutical product, including biopharmaceuticals. approval can require several years of clinical trials, including trials with human volunteers. Even after the drug is released, it will still be monitored for performance and safety risks.
Project Range: $7M-$500M+
If you have a patent or clinical trials that you need financing for, please contact us and let's see what we can develop together.
Winner of 2009's Best of Business Award by the SBCA!